RxDoctor Payments DataLook up a doctor →

Shamaila Aslam

Internal Medicine · Tomball, TXNPI 1992748545

Payments from drug & device makers

$7,503,084in general payments, 2019–2025

Across 591 payments — averaging $12,696 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.2M
  • Novartis$2.1M
  • Janssen Research & Development, LLC$1M
  • AbbVie$815K
  • Pfizer$758K
  • Amgen$412K
  • plus $255K from 17 others
$9,704in research payments, 2019–2025

Across 15 payments — averaging $646.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K
  • AbbVie$889

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,503,084 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Other internal medicine in Tomball

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →